Clarion’s Life Sciences portfolio operates under the Phacilitate brand and specifically serves the advanced therapies space. Phacilitate occupy a unique position in the market, providing an impressive range of global services to the full advanced therapies ecosystem. Our focus on the business and science of advanced therapies is a winning formula that promises to help advance a new standard in healthcare.
Phacilitate brings people together through inspiring conferences and Advanced Therapies Week and Advanced Therapies Europe are the pillars of our calendar. Our conferences have been connecting the world of advanced therapies since 2004, bringing together a diverse range of expertise from all corners of the globe.
Phacilitate also creates market intelligence and builds vibrant communities by creating game-changing partnerships that empowers industry. We are constantly looking to the horizon and what’s coming next and as the industry grows at an unprecedented rate, so does the scale and range of our offerings.